Xact Bio, Inc. funding
Xact Bio, Inc., a biotechnology company based in Boston, MA (founded 2024), filed a Form D with the SEC on September 28, 2026 and reported $10M raised of a $18M offering.
Amount raised$10M
Offering size$18M
Filed with the SECSeptember 28, 2026
First saleSeptember 11, 2026
IndustryBiotechnology
SecuritiesEquity
LocationBoston, MA
Founded2024
Entity typeCorporation
Investors so far3
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 28
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health CareFresenius Medical Care Will Clayton, LLC$3.8M · Sep 21Other Health Care